Clinical Use of Dostarlimab in Advanced Stage and Recurrent Endometrial Cancer: Patient Selection and Perspectives
Alyssa C Bujnak,1 Brittany File,2 Krishnansu S Tewari1 1Department of Gynecologic Oncology, University of California, Irvine-Medical Center, Orange, California, USA; 2Department of Obstetrics and Gynecology, University of California, Irvine-Medical Center, Orange, California, USACorrespondence: Alys...
Saved in:
Main Authors: | Bujnak AC, File B, Tewari KS |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-01-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/clinical-use-of-dostarlimab-in-advanced-stage-and-recurrent-endometria-peer-reviewed-fulltext-article-CMAR |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful Neoadjuvant Therapy with Pembrolizumab Monotherapy for Advanced Ascending Colon Cancer
by: Chien-Tzu Huang*, et al.
Published: (2023-07-01) -
Durable Clinical Benefit after Dual Checkpoint Inhibition and Single-agent Nivolumab Following Pembrolizumab Failure in Mismatch Repair-deficient Colon Cancer
by: Yat-Fung Chow, et al.
Published: (2023-10-01) -
Efficacy and safety of PD-1/PD-L1 inhibitors in advanced or recurrent endometrial cancer: a meta-analysis with trial sequential analysis of randomized controlled trials
by: Ji Ren, et al.
Published: (2025-01-01) -
Cost-effectiveness analysis of durvalumab with chemotherapy and maintenance durvalumab with or without olaparib for advanced endometrial cancer
by: Jiahao Zhang, et al.
Published: (2025-01-01) -
Lynch syndrome screening in colorectal and endometrial cancers in Iceland
by: Katla R. Kluvers, et al.
Published: (2025-01-01)